MedPath

efficacy of adjunctive moxibustion in the treatment of Tuberculosis

Not Applicable
Recruiting
Conditions
Tuberculosis
Registration Number
PACTR201504001033387
Lead Sponsor
Moxafrica
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
180
Inclusion Criteria

Diagnosis of TB was by sputum smear
-If Patient has been on TB treatment; it is for not more than 2 weeks
-Patient should consent to join the study if he/she is to join it.
-Patient should have an attendant who may help him/her with the treatment.

Exclusion Criteria

-Patient is under the age of 18 years
-Patient who were judged to be unable to understand the instructions (of what they are to do while in the study e.g. how to use moxa)
-Patients intending to leave/change treatment center before their TB treatment duration ends
-Patients who are unable to come on all follow up visits
-History of Allergy to moxa/moxibustion
-Diabetic patients were excluded
-pregnant women
-Coexistance of a Type of TB, or any other illnesses that require the participants to take steroids in addition to TB medicine
-If TB was not diagnosed using sputum smears.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath